123 related articles for article (PubMed ID: 20824400)
1. Hemorrhagic colonic ulcers caused by dasatinib for chronic myelogenous leukemia.
Ono Y; Mori T; Kato J; Yamane A; Yajima T; Iwao Y; Hibi T; Okamoto S
Int J Hematol; 2010 Oct; 92(3):556-8. PubMed ID: 20824400
[No Abstract] [Full Text] [Related]
2. The combination of thymosin and methylprednisolone for the treatment of a patient with colonic ulcers, subcutaneous nodules, and pleural effusion after dasatinib treatment for chronic myeloid leukemia.
Chen J; Zheng Z; Shen J; Zhou Y
Leuk Lymphoma; 2010 May; 51(5):941-3. PubMed ID: 20350280
[No Abstract] [Full Text] [Related]
3. Dasatinib-induced pulmonary hypertension in chronic myelogenous leukaemia.
Yun S; Anwer F; Vincelette ND
BMJ Case Rep; 2014 Apr; 2014():. PubMed ID: 24810451
[No Abstract] [Full Text] [Related]
4. Dasatinib-induced leukotrichia in a patient with chronic myelogenous leukemia.
Samimi S; Chu E; Seykora J; Loren A; Vittorio C; Rook A; Rosenbach M; Kim EJ
JAMA Dermatol; 2013 May; 149(5):637-9. PubMed ID: 23677113
[No Abstract] [Full Text] [Related]
5. Dasatinib in chronic myelogenous leukemia.
Kathula SK
N Engl J Med; 2006 Sep; 355(10):1062; author reply 1063-4. PubMed ID: 16957155
[No Abstract] [Full Text] [Related]
6. Dasatinib: a tyrosine kinase inhibitor for the treatment of chronic myelogenous leukemia and philadelphia chromosome-positive acute lymphoblastic leukemia.
Steinberg M
Clin Ther; 2007 Nov; 29(11):2289-308. PubMed ID: 18158072
[TBL] [Abstract][Full Text] [Related]
7. Viral infection or reactivation in patients during treatment with dasatinib: a call for screening?
Torres HA; Chemaly RF
Leuk Lymphoma; 2007 Dec; 48(12):2308-9. PubMed ID: 18067004
[No Abstract] [Full Text] [Related]
8. Double-edged sword of the new cancer therapeutics.
Force T
Circulation; 2012 May; 125(17):2057-8. PubMed ID: 22451582
[No Abstract] [Full Text] [Related]
9. Development of severe sclerotic chronic GVHD during treatment with dasatinib.
Pulanic D; Cowen EW; Baird K; Bishop MR; Pavletic SZ
Bone Marrow Transplant; 2010 Sep; 45(9):1469-70. PubMed ID: 20062096
[No Abstract] [Full Text] [Related]
10. Acute colitis presenting with hematochezia in a patient with chronic myeloid leukemia during dasatinib therapy.
Eskazan AE; Hatemi İ; Öngören Aydın S; Ar MC; Soysal T
Turk J Gastroenterol; 2014 Dec; 25 Suppl 1():233. PubMed ID: 25910316
[No Abstract] [Full Text] [Related]
11. Parvovirus B19 acute infection and a reactivation of cytomegalovirus and herpesvirus 6 in a chronic myeloid leukemia patient during treatment with dasatinib (BMS-354825).
García-Muñoz R; Galar A; Moreno C; Rodríguez-Otero P; Panizo-Morgado E; Ponz-Sarvisê M; Fernandez-Alonso M; Rubio M; Merino J; Cuesta B; Panizol C; Prosper F
Leuk Lymphoma; 2007 Dec; 48(12):2461-4. PubMed ID: 18067026
[No Abstract] [Full Text] [Related]
12. Gynecomastia in a male after dasatinib treatment for chronic myeloid leukemia.
Caocci G; Atzeni S; Orrù N; Azzena L; Martorana L; Littera R; Ledda A; La Nasa G
Leukemia; 2008 Nov; 22(11):2127-8. PubMed ID: 18463676
[No Abstract] [Full Text] [Related]
13. Reversible dasatinib-related pulmonary arterial hypertension diagnosed by noninvasive echocardiography.
Wang HC; Lee CS; Liu TC
Kaohsiung J Med Sci; 2015 Mar; 31(3):165-6. PubMed ID: 25744241
[No Abstract] [Full Text] [Related]
14. Successful pregnancy involving a man with chronic myeloid leukemia on dasatinib.
Oweini H; Otrock ZK; Mahfouz RA; Bazarbachi A
Arch Gynecol Obstet; 2011 Jan; 283(1):133-4. PubMed ID: 20473616
[TBL] [Abstract][Full Text] [Related]
15. Reversible lymph node follicular hyperplasia associated with dasatinib treatment of chronic myeloid leukemia in chronic phase.
Roux C; Nicolini FE; Rea D; Niault M; Mollica L; Berger F; Chassagne-Clément C; Tigaud I; Tulliez M; Giraudier S; Turhan A; Rousselot P; Legros L
Blood; 2013 Oct; 122(17):3082-4. PubMed ID: 24159167
[No Abstract] [Full Text] [Related]
16. Dasatinib-induced lupus.
Rea D; Bergeron A; Fieschi C; Bengoufa D; Oksenhendler E; Dombret H
Lancet; 2008 Aug; 372(9640):713-4. PubMed ID: 18761212
[No Abstract] [Full Text] [Related]
17. The toxicities of modern targeted therapies: learning from the price of progress.
Giles FJ
Target Oncol; 2009 Apr; 4(2):65-6. PubMed ID: 19357815
[No Abstract] [Full Text] [Related]
18. The incidence of pleural and pericardial effusion is not higher in patients receiving dasatinib at low doses. (Reply).
Visani G; Breccia M; Montefusco E; Morra E; Santini V; Isidori A
Haematologica; 2011 Apr; 96(4):e23-4; author reply e25. PubMed ID: 21454871
[No Abstract] [Full Text] [Related]
19. Severe dyspnoea in a patient with chronic myelogenous leukaemia on a tyrosine kinase inhibitor.
Ustun C; Randall N; Podgaetz E; Amin K; Dincer HE
Thorax; 2015 Jul; 70(7):701-4. PubMed ID: 25935168
[No Abstract] [Full Text] [Related]
20. Dasatinib: for some difficult cases of adult leukaemia.
Prescrire Int; 2008 Aug; 17(96):149-50. PubMed ID: 19496239
[No Abstract] [Full Text] [Related]
[Next] [New Search]
